The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
分析师格局：对爱奥尼斯制药的8种看法
Ratings for Ionis Pharmaceuticals (NASDAQ:IONS) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，有8位分析师提供了爱奥尼斯制药公司（纳斯达克股票代码：IONS）的评级，显示了看涨和看跌的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $67.12, a high estimate of $82.00, and a low estimate of $60.00. This current average has decreased by 3.29% from the previous average price target of $69.40.
分析师12个月目标股价的见解已经公布，平均目标股价为67.12美元，最高估计为82.00美元，低估值为60.00美元。目前的平均价格较之前的平均目标价69.40美元下降了3.29％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析师评级：深度分析
The analysis of recent analyst actions sheds light on the perception of Ionis...
对分析师近期行为的分析揭示...
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。